- Home
- / MILAE BIORESOURCES
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
MILAE BIORESOURCES financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
₩4.4 K
2024-10-29
Market Capitalization
₩86.6 B
2024-10-29
Revenue
₩62.5 B
FY, 2024
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| KRW | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 35.2B | 50.1B | 47.5B | 66.7B | 75.6B | 60.0B | 62.5B |
| Cost of goods sold | 28.9B | 43.4B | 39.6B | 57.6B | 65.1B | 50.6B | 53.8B |
| Gross profit | 6.4B | 6.7B | 7.9B | 9.1B | 10.5B | 9.6B | 8.6B |
| Gross profit margin, % | 13.4% | 16.7% | 13.6% | 13.9% | 16.0% | 13.8% | |
| Operating expense total | 4.1B | 4.6B | 5.7B | 6.3B | 7.9B | 8.4B | 7.3B |
| Depreciation and amortization | 282.7M | 657.6M | 720.2M | 920.8M | 1.0B | 1.4B | 2.0B |
| EBITDA | 2.3B | 2.1B | 2.2B | 2.8B | 2.6B | 1.2B | 1.4B |
| EBITDA margin, % | 4.2% | 4.6% | 4.3% | 3.5% | 2.0% | 2.2% | |
| EBIT | 2.0B | 1.4B | 1.2B | 1.8B | 1.5B | (197.7M) | (805.5M) |
| EBIT margin, % | 2.7% | 2.5% | 2.8% | 2.0% | -0.3% | -1.3% | |
| Interest income | 187.3M | 184.6M | 135.6M | 116.7M | 366.8M | 1.0B | 731.3M |
| Interest expense | 266.1M | 312.0M | 235.4M | 778.2M | 685.4M | 399.6M | 439.5M |
| Pre tax profit | 1.9B | 1.3B | 1.0B | 1.1B | 905.4M | 392.9M | (517.3M) |
| Income tax expense | 114.3M | 220.4M | 81.1M | 65.3M | 27.2M | 33.7M | (97.6M) |
| Net Income | 1.8B | 1.0B | 953.2M | 1.1B | 878.1M | 359.2M | (419.7M) |